Commodore Capital’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-1,375,000
| Closed | -$54.5M | – | 43 |
|
2024
Q1 | $54.5M | Sell |
1,375,000
-235,000
| -15% | -$9.32M | 3.64% | 9 |
|
2023
Q4 | $30.7M | Buy |
1,610,000
+285,000
| +22% | +$5.43M | 2.68% | 14 |
|
2023
Q3 | $15.2M | Hold |
1,325,000
| – | – | 1.77% | 18 |
|
2023
Q2 | $13.6M | Hold |
1,325,000
| – | – | 1.53% | 21 |
|
2023
Q1 | $10.2M | Hold |
1,325,000
| – | – | 1.56% | 20 |
|
2022
Q4 | $9.74M | Hold |
1,325,000
| – | – | 1.47% | 24 |
|
2022
Q3 | $9.54M | Buy |
+1,325,000
| New | +$9.54M | 1.53% | 21 |
|